Take for example Natco Pharmaceutical that will launch ‘Semanat’ and ‘Semafull’ in 2 mg, 4 mg and 8 mg doses. The drug will cost Rs 1,290 per month for the lowest dose and Rs 1,750 for the highest one, according to the company. It will also launch an easy-to-inject pen device next month in the same three doses that will cost Rs 4,000, Rs 4,200, and Rs 4,500 respectively. On the other hand, there will be cost-sensitive patients for whom the price point of generics will be attractive. It must be ensured that the drug is dispensed only with a prescription and must not be used in weight loss programmes by non-physicians.

Source: Indian Express March 20, 2026 10:35 UTC